Insider · CIK 0001657768
Ken Takanashi
Files at WVE (Wave Life Sciences Ltd.). First filing Aug 7, 2025, latest Aug 13, 2026.
In brief
Ken Takanashi files SEC Form 4 as director at WVE (Wave Life Sciences Ltd.). Since Aug 7, 2025, Ken Takanashi has reported 0 open-market buys worth $0 and 2 open-market sells worth $66k, the latest filed on Aug 13, 2026.
A track record needs three past buys with six months of prices behind them; Ken Takanashi has 0, so none is measured yet.
The newest scored trade: sold $23k of WVE on Aug 11, 2026, filed Aug 13, 2026, scored 15 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $23k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
WVE: Wave Life Sciences Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Wave Life Sciences Ltd. | $23k 3,864 shares | -16% | 0% from low-76% from high | |
| 16Weak | Wave Life Sciences Ltd. | $43k 4,872 shares | -0% | +66% from low-46% from high |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | WVE Wave Life Sciences Ltd. | AGrant or award Common Stock | +10,700 | $0.00 | $0 | 30,779 | 7 d ago |
| Oct 5, 2026 | WVE Wave Life Sciences Ltd. | AGrant or award Stock Option (right to buy)derivative | +64,000 | $0.00 | $0 | 64,000 | 7 d ago |
| Aug 11, 2026 | WVE Wave Life Sciences Ltd. | SOpen-market sale Common Stock10b5-1 | -3,864 | $6.01 | $23k | 20,079 | Aug 13, 2026 |
| Mar 23, 2026 | WVE Wave Life Sciences Ltd. | CConversion Ordinary Sharesindirect: See Footnote | +3,901,348 | $0.00 | $0 | 9,606,408 | Mar 26, 2026 |
| Mar 23, 2026 | WVE Wave Life Sciences Ltd. | CConversion Series A Preferred Sharesderivativeindirect: See Footnote | -3,901,348 | $0.00 | $0 | 0 | Mar 26, 2026 |
| Aug 11, 2025 | WVE Wave Life Sciences Ltd. | AGrant or award Ordinary Shares | +12,700 | $0.00 | $0 | 5,729,003 | Aug 13, 2025 |
| Aug 11, 2025 | WVE Wave Life Sciences Ltd. | AGrant or award Share Option (right to buy)derivative | +76,200 | $0.00 | $0 | 76,200 | Aug 13, 2025 |
| Aug 5, 2025 | WVE Wave Life Sciences Ltd. | SOpen-market sale Ordinary Shares10b5-1 | -4,872 | $8.75 | $43k | 5,716,303 | Aug 7, 2025 |
Questions about Ken Takanashi
Answered from the filings on this page, as of the latest one.
Is Ken Takanashi buying or selling?
In the last 12 months Ken Takanashi reported 0 open-market buys worth $0 and 1 open-market sell worth $23k on SEC Form 4; the latest was sold $23k of WVE on Aug 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Ken Takanashi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ken Takanashi has 0.
Where does Ken Takanashi file Form 4?
Ken Takanashi has filed Form 4 at WVE (Wave Life Sciences Ltd.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.